Blend Labs Inc (BLND) concluded trading on Thursday at a closing price of $3.51, with 4.86 million shares of worth about $17.04 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -5.14% during that period and on February 27, 2025 the price saw a loss of about -3.57%. Currently the company’s common shares owned by public are about 252.13M shares, out of which, 204.16M shares are available for trading.
Stock saw a price change of -10.91% in past 5 days and over the past one month there was a price change of -10.46%. Year-to-date (YTD), BLND shares are showing a performance of -16.63% which increased to 48.10% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.08 but also hit the highest price of $5.53 during that period. The average intraday trading volume for Blend Labs Inc shares is 3.02 million. The stock is currently trading -8.68% below its 20-day simple moving average (SMA20), while that difference is down -11.36% for SMA50 and it goes to -2.89% lower than SMA200.
Blend Labs Inc (NYSE: BLND) currently have 252.13M outstanding shares and institutions hold larger chunk of about 51.75% of that.
The stock has a current market capitalization of $898.31M and its 3Y-monthly beta is at 1.37. It has posted earnings per share of -$0.34 in the same period. It has Quick Ratio of 3.21. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BLND, volatility over the week remained 6.43% while standing at 5.28% over the month.
Stock’s fiscal year EPS is expected to rise by 150.93% while it is estimated to increase by 91.81% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JMP Securities on December 18, 2024 offering a Mkt outperform rating for the stock and assigned a target price of $7 to it. Coverage by Canaccord Genuity stated Blend Labs Inc (BLND) stock as a Buy in their note to investors on August 12, 2024, suggesting a price target of $4.75 for the stock. On August 09, 2024, William Blair Upgrade their recommendations, while on December 20, 2023, Wells Fargo Upgrade their ratings for the stock with a price target of $3.50. Stock get a Mkt perform rating from Keefe Bruyette on November 14, 2022.
